Cargando…
264. Anti-platelet Therapy Significantly Reduces Inpatient Mortality in Patients with Staphylococcus aureus Bacteremia
BACKGROUND: There is a growing body of evidence which suggests that P2Y12 inhibitors may have antibacterial properties in vivo. To our knowledge, this has not been previously examined using real world clinical data from patients with specific infections. METHODS: Our retrospective cohort study inclu...
Autores principales: | Caffrey, Aisling, O’Neill, Emily T, Lopes, Vrishali, Ulloa, Erlinda R, Sakoulas, George, Nizet, Victor, LaPlante, Kerry |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7778087/ http://dx.doi.org/10.1093/ofid/ofaa439.308 |
Ejemplares similares
-
1067. Comparative Effectiveness of Nafcillin or Oxacillin, Cefazolin, and Piperacillin/Tazobactam in Methicillin-Sensitive Staphylococcus aureus Bacteremia
por: Beganovic, Maya, et al.
Publicado: (2018) -
Impact of Vancomycin-Associated Acute Kidney Injury on Patient Outcomes in MRSA Bacteremia
por: Luther, Megan, et al.
Publicado: (2017) -
255. Ticagrelor Aids Platelet-Mediated Clearance in a Refractory Staphylococcus aureus Endovascular Infection with Septic Emboli
por: Ulloa, Erlinda, et al.
Publicado: (2020) -
Proton-pump inhibitors do not influence clinical outcomes in patients with Staphylococcus aureus bacteremia
por: Caffrey, Aisling R., et al.
Publicado: (2019) -
217. Combination Salvage Therapy with Cefazolin Plus Ertapenem for Refractory Methicillin-Susceptible Staphylococcus aureus Bacteremia
por: Rose Ulloa, Erlinda, et al.
Publicado: (2019)